Log in
Enquire now
‌

US Patent 11028050 Salts and polymorphs of a PDE4 inhibitor

Patent 11028050 was granted and assigned to Tetra Therapeutics on June, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Tetra Therapeutics
Tetra Therapeutics
0
Current Assignee
Tetra Therapeutics
Tetra Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
110280500
Patent Inventor Names
Stephan D. Parent0
Jon P. Lawson0
Mark E. Gurney0
Richard James Ely0
Date of Patent
June 8, 2021
0
Patent Application Number
168512030
Date Filed
April 17, 2020
0
Patent Citations Received
‌
US Patent 11767334 Heteroaryl inhibitors of PDE4
Patent Primary Examiner
‌
Timothy R Rozof
0
Patent abstract

Provided herein are free base crystalline forms and crystalline salts of Compound 1.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11028050 Salts and polymorphs of a PDE4 inhibitor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.